Skip to main content
Premium Trial:

Request an Annual Quote

Orchid Cellmark Reports 15.4-Percent Decline in Q4 Revenues as Profits Turn to Loss

NEW YORK, May 19 (GenomeWeb News) - Orchid Cellmark reported today a 15.4-percent decrease in revenues and a 5.5-percent decrease in net income for the fourth quarter of 2005.


Revenues for the three months ended Dec. 31, 2005declined to $13.9 million from $16.5 million in the year-ago period. Orchid said revenues in the period were "primarily impacted" by a decline in the company's US forensic casework testing volume.


"This decline was primarily due to lower than anticipated production capacity in the company's new Dallas, Texas facility as a result of the transition of work to this facility from the company's Germantown, Maryland facility, which was closed in September 2005, and lower than expected DNA analyst staffing levels," Orchid said.


In addition, UK agricultural revenues declined by $1.1 million in the fourth quarter of 2005 with the expiration of the Maple Leaf contract. Orchid said fourth-quarter revenue grew in US private paternity, US CODIS database, and UK forensic DNA testing services.


R&D expenses for the fourth quarter grew 27.2 percent to 426,000 from 335,000 in Q4 2004.


Orchid Cellmark's net income for the fourth quarter declined to a loss of $3.8 million from a profit of $845,000 in Q4 2004.


As of Dec. 31, 2005, Orchid Cellmark had approximately $23.2 million in cash and cash equivalents.


Orchid on  April 7 said it would restate its earnings for the second and third quarters of 2005 due to a non-cash, non-operating income event during the second quarter.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.